Provided by Tiger Trade Technology Pte. Ltd.

Lineage

41.24
+0.44001.08%
Post-market: 41.240.00000.00%16:10 EDT
Volume:577.59K
Turnover:23.74M
Market Cap:9.36B
PE:-57.28
High:41.41
Open:41.41
Low:40.31
Close:40.80
52wk High:45.75
52wk Low:31.33
Shares:227.08M
Float Shares:57.19M
Volume Ratio:0.82
T/O Rate:1.01%
Dividend:2.12
Dividend Rate:5.14%
EPS(TTM):-0.7200
EPS(LYR):-0.4300
ROE:-2.04%
ROA:0.75%
PB:1.19
PE(LYR):-95.91

Loading ...

Lineage declares Q1 2026 cash dividend of USD 0.53 per share

Reuters
·
Mar 14

Press Release: Lineage, Inc. Declares Increased Dividend for First-Quarter 2026

Dow Jones
·
Mar 14

Top Executive Makes Bold Insider Move at Lineage Therap

TIPRANKS
·
Mar 13

Lineage chairman buys $438.3K in common stock

TIPRANKS
·
Mar 12

Lineage Co-Executive Chairman Kevin Patrick Marchetti Acquires Common Shares

Reuters
·
Mar 12

Lineage Is Maintained at Sector Perform by Scotiabank

Dow Jones
·
Mar 12

Lineage price target raised to $42 from $39 at Scotiabank

TIPRANKS
·
Mar 11

Lineage Therap Expands ATM Equity Offering Capacity

TIPRANKS
·
Mar 11

Lineage Cell Therapeutics Extends Runway Amid R&D Surge

TIPRANKS
·
Mar 08

Regulatory Risks Loom for Lineage Cell Therapeutics as Legacy Pluripotent Cell Lines Face Potential Compliance Challenges

TIPRANKS
·
Mar 07

Lineage Cell Therapeutics Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Mar 07

Lineage Cell Therapeutics reports Q4 EPS 0c vs (2c) last year

TIPRANKS
·
Mar 06

Lineage Cell Therapeutics Q4 EPS $0.00 Beats $(0.05) Estimate, Sales $6.600M Beat $2.577M Estimate

Benzinga Earnings
·
Mar 06

Lineage Is Maintained at Buy by Truist Securities

Dow Jones
·
Mar 04

Lineage, Inc. (LINE) Receives a Buy from Truist Financial

TIPRANKS
·
Mar 04

Truist Raises Price Target on Lineage to $44 From $41, Keeps Buy Rating

MT Newswires Live
·
Mar 04

Assessing Lineage (NasdaqGS:LINE) Valuation After Q4 Profit Swing And Narrowed Annual Net Loss

Simply Wall St.
·
Mar 03

Lineage Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Mar 03

Lineage price target raised to $44 from $42 at RBC Capital

TIPRANKS
·
Mar 02

RBC Raises Price Target on Lineage to $44 From $42, Keeps Outperform Rating

MT Newswires Live
·
Mar 02